Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$4.86 - $8.19 $23,736 - $39,999
4,884 Added 29.92%
21,206 $139,000
Q4 2023

Feb 09, 2024

BUY
$3.37 - $6.86 $55,005 - $111,968
16,322 New
16,322 $106,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.29 $88,942 - $160,822
12,101 New
12,101 $106,000
Q4 2022

Feb 13, 2023

BUY
$4.62 - $10.18 $72,575 - $159,917
15,709 New
15,709 $160,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $217M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.